Analysed VERA THERAPEUTICS INC (VERA:NASDAQ) News Sources
Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
15-09-2026
yahoo.com
VERA Stock Jumps 16% Premarket – Trutakna Cuts Kidney Disease Progression Risk By 76%, Full FDA Filing Planned In Q4
15-09-2026
stocktwits.com
Vera Therapeutics Shares Rise 13% After TRUTAKNA Meets ORIGIN 3 Trial Endpoints
15-09-2026
advfn.com
Vera set up for full approval for Trutakna in IgAN with Phase III win
15-09-2026
clinicaltrialsarena.com
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
02-10-2026
yahoo.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-10-2026
yahoo.com
What is the current price of VERA THERAPEUTICS INC (VERA:NASDAQ)?
The current price of VERA THERAPEUTICS INC (VERA:NASDAQ) is $29.92.
VERA THERAPEUTICS INC (VERA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is $0.19.
VERA THERAPEUTICS INC (VERA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is 0.6391%.
What is the most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ) is .
SEC-8K** Filing Available For VERA THERAPEUTICS INC (VERA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.